Background Historically, corticosteroids have been the most commonly used class of
medication for induction of remission in Crohn's disease (CD). Corticosteroids down …

Background Tumour necrosis factor (TNF)‐alpha inhibitors are a major advance in the
management of inflammatory bowel disease but increase the risk for tuberculosis (TB). Aim …

Crohn's disease is a chronic, transmural inflammatory process of the gastrointestinal tract. It
often affects the colon with the perianal area. The most common intestinal manifestations …

Abstract Information on safety and efficacy of adalimumab in children with Crohn's disease
(CD) is limited. We present a case-series of 14 children with severe CD treated with …

Inflammatory bowel disease (IBD) is a condition of the intestine with significant morbidity.
Although hereditary, environmental, immunologic, and bacterial factors have been …

The use of biological agents in inflammatory bowel diseases across the Asia‐Pacific region
is increasing. As new molecules and targets are identified, knowledge regarding the …

Infliximab is an anti-tumor necrosis factor (TNF) used for treatment of inflammatory bowel
disease (IBD) as well as rheumatoid arthritis, psoriasis, and other inflammatory conditions …

Background A new technique of gene regulation, termed RNA interference, has emerged
recently. RNA interference utilizes short double‐stranded RNA to inhibit selectively gene …

Résumé La maladie de Crohn et la rectocolite hémorragique sont les maladies
inflammatoires chroniques de l'intestin les plus fréquentes dans les pays occidentaux avec …

Цель. Проанализировать видовой состав и чувствительность к антибиотикам
микрофлоры, выделенной из биопсийного материала у больных с неспецифическим …